Skip to main content
Fig. 8 | Stem Cell Research & Therapy

Fig. 8

From: Exosomes derived from mesenchymal stem cells primed with disease-condition-serum improved therapeutic efficacy in a mouse rheumatoid arthritis model via enhanced TGF-β1 production

Fig. 8

Experimental schedule and changes in cytokines after Exo-RA treatment in a mouse model of RA. A Experimental schedule and experimental groups according to administered material. B Changes in cytokines after Exo-RA treatment in a mouse model of RA. CFA, complete Freund’s adjuvant; IFA, incomplete Freund’s adjuvant. iv: intravenous injection; ip: intraperitoneal injection; FBS: fetal bovine serum; Exo-RA: exosomes derived from the supernatant of 2 × 106 iMSCs primed with RA serum

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512